Skip to main navigation Skip to search Skip to main content

A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51

  • Najim Ameziane
  • , Patrick May
  • , Anneke Haitjema
  • , Henri J. Van De Vrugt
  • , Sari E. Van Rossum-Fikkert
  • , Dejan Ristic
  • , Gareth J. Williams
  • , Jesper Balk
  • , Davy Rockx
  • , Hong Li
  • , Martin A. Rooimans
  • , Anneke B. Oostra
  • , Eunike Velleuer
  • , Ralf Dietrich
  • , Onno B. Bleijerveld
  • , Maarten Altelaar
  • , Hanne Meijers-Heijboer
  • , Hans Joenje
  • , Gustavo Glusman
  • , Jared Roach
  • Leroy Hood, David Galas, Claire Wyman, Rudi Balling, Johan Den Dunnen, Johan P. De Winter, Roland Kanaar, Richard Gelinas*, Josephine C. Dorsman
*Corresponding author for this work
  • Vrije Universiteit Amsterdam
  • Institute for Systems Biology
  • Antoni van Leeuwenhoek-The Netherlands Cancer Institute
  • Erasmus University Rotterdam
  • University of California Office of the President
  • External unknown
  • Heinrich Heine University Düsseldorf
  • Deutsche Fanconi-Anämie-Hilfe E.V.
  • Mass Spectrometry/Proteomics Facility
  • Pacific Northwest Diabetes Research Institute
  • Luxembourg Centre for Systems Biomedicine
  • Leiden University Medical Center

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Fanconi anaemia (FA) is a hereditary disease featuring hypersensitivity to DNA cross-linker-induced chromosomal instability in association with developmental abnormalities, bone marrow failure and a strong predisposition to cancer. A total of 17 FA disease genes have been reported, all of which act in a recessive mode of inheritance. Here we report on a de novo g.41022153G>A; p.Ala293Thr (NM-002875) missense mutation in one allele of the homologous recombination DNA repair gene RAD51 in an FA-like patient. This heterozygous mutation causes a novel FA subtype, 'FA-Rffrt ', which appears to be the first subtype of FA caused by a dominant-negative mutation. The patient, who features microcephaly and mental retardation, has reached adulthood without the typical bone marrow failure and paediatric cancers. Together with the recent reports on RAD51-associated congenital mirror movement disorders, our results point to an important role for RAD51-mediated homologous recombination in neurodevelopment, in addition to DNA repair and cancer susceptibility.

Original languageEnglish
Article number8829
JournalNature Communications [E]
Volume6
DOIs
Publication statusPublished - 18 Dec 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51'. Together they form a unique fingerprint.

Cite this